Gentiva Health Services
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Gentiva Health Services's revenues will decrease -4.7% and EPS will grow 3.7%.
The average estimate for revenue is $428.4 million. On the bottom line, the average EPS estimate is $0.28.
Revenue details
Last quarter, Gentiva Health Services tallied revenue of $427.7 million. GAAP reported sales were 4.7% lower than the prior-year quarter's $448.7 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS details
Last quarter, non-GAAP EPS came in at $0.35. GAAP EPS of $0.46 for Q2 were 171% higher than the prior-year quarter's $0.17 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
Recent performance
For the preceding quarter, gross margin was 47.9%, 10 basis points better than the prior-year quarter. Operating margin was 9.6%, 20 basis points worse than the prior-year quarter. Net margin was 3.3%, 210 basis points better than the prior-year quarter.
Looking ahead
The full year's average estimate for revenue is $1.73 billion. The average EPS estimate is $1.23.
Investor sentiment
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 278 members out of 298 rating the stock outperform, and 20 members rating it underperform. Among 90 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 85 give Gentiva Health Services a green thumbs-up, and five give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Gentiva Health Services is hold, with an average price target of $7.90.
- Add Gentiva Health Services to My Watchlist.